Page 7 of 12
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
procedure E (157 mg, 86%), general procedure F (161 mg, 88%),
petroleum ether/ethyl acetate (20:1), colorless oil; 1H NMR (400
MHz, CDCl3) δ 7.32 – 7.23 (m, 3H), 7.15 (d, J = 8.1 Hz, 2H), 6.95
– 6.86 (m, 4H), 3.87 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 148.4,
142.7, 133.0, 129.3, 121.2, 120.9, 120.0, 118.6, 114.8, 110.6,
55.6.
eluting with petroleum ether/ethyl acetate (20:1), white solid; 1H
NMR (400 MHz, CDCl3) δ 7.23 (t, J = 7.6 Hz, 2H), 7.11 – 7.06 (m,
2H), 7.04 – 6.97 (m, 4H), 6.88 (t, J = 7.2 Hz, 1H), 2.30 (s, 3H). 13
C
NMR (100 MHz, CDCl3) δ 144.0, 140.3, 131.0, 129.9, 129.4,
3,5-Dimethyl-N-phenylaniline (10a).21 General procedure A
(183 mg, 93%), eluting with petroleum ether/ethyl acetate (20:1),
white solid; 1H NMR (400 MHz, CDCl3) δ 7.25 (t, J = 7.7 Hz, 2H),
7.05 (d, J = 8.0 Hz, 2H), 6.91 (t, J = 7.3 Hz, 1H), 6.70 (s, 2H), 6.59
(s, 1H), 2.26 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 143.5, 143.2,
139.1, 129.4, 123.0, 120.9, 118.0, 115.8, 21.5.
9
120.4, 119.0, 116.9, 20.8.
Diphenylamine (4a).19 General procedure A (152 mg, 90%),
general procedure B (133 mg, 79%), general procedure E (147
mg, 87%), general procedure F (152 mg, 90%), eluting with
petroleum ether/ethyl acetate (20:1), white solid; 1H NMR (400
MHz, CDCl3) δ 7.26 (t, J = 7.6 Hz, 4H), 7.07 (d, J = 8.0 Hz, 4H),
6.92 (t, J = 7.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 143.3,
129.5, 121.2, 118.0.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
N-phenylbenzo[d][1,3]dioxol-5-amine
(11a).15a
General
procedure A ( 170 mg, 80%), general procedure F (177 mg, 83%),
eluting with petroleum ether/ethyl acetate (10:1), colorless oil; 1H
NMR (400 MHz, CDCl3) δ 7.24 (t, J = 7.5 Hz, 2H), 6.94 (d, J = 7.9
Hz, 2H), 6.88 (t, J = 7.3 Hz, 1H), 6.75 (d, J = 8.2 Hz, 1H), 6.71 (s,
1H), 6.56 (d, J = 8.2 Hz, 1H), 5.93 (s, 2H); 13C NMR (100 MHz,
CDCl3) δ 148.3, 144.7, 142.9, 137.3, 129.4, 120.1, 116.4, 113.0,
108.6, 102.6, 100.1.
4-Chloro-N-phenylaniline (5a).19 General procedure A (158
mg, 78%), general procedure F (164 mg, 81%), eluting with
petroleum ether/ethyl acetate (20:1), white solid; 1H NMR (400
MHz, CDCl3) δ 7.27 (t, J = 7.8 Hz, 2H), 7.20 (d, J = 8.5 Hz, 2H),
7.04 (d, J = 7.9 Hz, 2H), 7.01 – 6.92 (m, 3H); 13C NMR (100 MHz,
CDCl3) δ 142.7, 142.0, 129.5, 129.3, 125.5, 121.6, 118.9, 118.2.
1-(4-(Phenylamino)phenyl)ethanone
(6a).19
General
N-phenylthiophen-3-amine (12a).21 General procedure
A(151mg, 86%), general procedure B (122 mg, 70%), general
procedure E (151 mg, 86%), general procedure F (145 mg, 83%),
eluting with petroleum ether/ethyl acetate (20:1), colorless oil; 1H
NMR (400 MHz, CDCl3) δ 7.26 – 7.22 (m, 3H), 7.00 (d, J = 7.8 Hz,
2H), 6.95 (d, J = 5.0 Hz, 1H), 6.90 (t, J = 7.3 Hz, 1H), 6.78 (s, 1H);
13C NMR (100 MHz, CDCl3) δ 144.7, 141.6, 129.5, 129.4, 125.2,
122.9, 119.9, 115.6, 106.5.
procedure (179 mg, 85%),
A
eluting
with
dichloromethane/methanol (20:1), yellow solid; 1H NMR (400 MHz,
CDCl3) δ 7.86 (d, J = 8.3 Hz, 2H), 7.34 (t, J = 7.6 Hz, 2H), 7.18 (d,
J = 7.8 Hz, 2H), 7.08 (t, J = 7.3 Hz, 1H), 6.99 (d, J = 8.2 Hz, 2H),
6.22 (s, 1H), 2.52 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 196.8,
148.7, 140.8, 130.7, 129.5, 123.2, 120.7, 114.4, 26.2.
4-Nitro-N-phenylaniline (7a). 19 General procedure C: (156 mg,
73%), general procedure D, eluting with petroleum ether/ethyl
acetate (10:1), (134 mg, 63%), general procedure F (161 mg,
75%): yellow solid; 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 9.1
Hz, 2H), 7.42 (t, J = 7.9 Hz, 2H), 7.29ꢀ7.20 (m, 3H), 6.97 (d, J =
9.1 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 150.4, 139.5, 129.7,
126.3, 124.6, 121.9, 113.7, 29.7.
N-Phenylpyridin-2-amine (13a).15a General procedure B (119 mg,
70%), general procedure
F (138 mg, 81%), eluting with
dichloromethane/methanol (20:1), white solid; 1H NMR (400 MHz,
CDCl3) δ 8.20 (d, J = 4.6 Hz, 1H), 7.47 (t, J = 7.8 Hz, 1H), 7.33 –
7.25 (m, 4H ), 7.06 – 7.03 (m, 2H), 6.88 (d, J = 8.4 Hz, 1H), 6.73 –
6.70 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 156.1, 148.3, 140.5,
137.7, 129.3, 122.8, 120.4, 115.0, 108.2.
N-phenyl-4-(trifluoromethyl)aniline (8a).19 General procedure
A (190 mg, 80%), general procedure B (170 mg, 72%), general
procedure E (194 mg, 82%), general procedure F (201 mg, 85%),
eluting with petroleum ether/ethyl acetate (20:1), white solid; 1H
NMR (400 MHz, CDCl3) δ 7.47 (d, J = 8.3 Hz, 2H), 7.33 (t, J = 7.6
Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 7.09 – 7.01 (m, 3H); 13C NMR
(100 MHz, CDCl3) δ 146.8, 141.2, 129.6, 126.8, 126.7, 126.7,
123.0, 121.8, 121.5, 120.1, 115.4.
2-(allyloxy)-N-phenylaniline.(14a). General procedure A (187
mg, 83% ), eluting with petroleum ether, colorless oil, MS(ESI+):
m/z: 226 ([M+H]+); 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.24 (m,
3H), 7.15 (d, J = 7.8 Hz, 2H), 6.97 – 6.78 (m, 4H), 6.14 – 6.01 (m,
1H), 5.40 (d, J = 17.2 Hz, 1H), 5.29 (d, J = 10.5 Hz, 1H), 4.59 (d, J
= 5.2 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 147.3, 142.8, 133.4,
129.4, 121.3, 121.2, 119.9, 118.8, 117.9, 114.9, 112.2, 69.6; IR
(KBr, cmꢀ1): 3415, 1230, 1648; Anal.Calcd for C15H15NO•0.3H2O:
C, 78.10; H, 6.82; N, 6.07; Found: C, 78.21; H, 6.80; N, 5.89.
2-Methoxy-N-phenylaniline (9a).15a General procedure A (141
mg, 71), general procedure B (140 mg,71%), general procedure E
(171 mg, 86%), general procedure F (165 mg, 83%), eluting with
G
ACS Paragon Plus Environment